Brunangelo Falini

Perugia, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 186 publications

Short BRAF+MEK coinhibition, alone and combined with anti-CD20 immunotherapy, in relapsed or refractory hairy cell leukemia: An investigator-sponsored multi-center phase 2 clinical trial.

Short BRAF+MEK coinhibition, alone and combined with anti-CD20 immunotherapy, in relapsed or refractory hairy cell leukemia: An investigator-sponsored multi-center phase 2 clinical trial.

Journal: HemaSphere
Published: April 30, 2026

Updated consensus guidelines for the diagnosis and management of patients with HCL and HCL variant.

Updated consensus guidelines for the diagnosis and management of patients with HCL and HCL variant.

Journal: Blood
Published: January 05, 2026

Updated consensus guidelines for the diagnosis and management of patients with hairy cell leukemia (HCL) and HCL-variant.

Updated consensus guidelines for the diagnosis and management of patients with hairy cell leukemia (HCL) and HCL-variant.

Journal: Blood
Published: January 05, 2026

Real-life efficacy and safety of vemurafenib plus rituximab in relapsed or refractory hairy-cell leukemia: A multicenter Italian retrospective study (HCL-PG03R).

Real-life efficacy and safety of vemurafenib plus rituximab in relapsed or refractory hairy-cell leukemia: A multicenter Italian retrospective study (HCL-PG03R).

Journal: HemaSphere
Published: September 08, 2025

CD30 as a Target Molecule in the Diagnosis and Therapy of Lymphomas.

CD30 as a Target Molecule in the Diagnosis and Therapy of Lymphomas.

Journal: American journal of hematology
Published: August 06, 2025

Neuroinflammatory changes in acute myeloid leukemia: Evidence for blood-brain barrier disruption and glial activation.

Neuroinflammatory changes in acute myeloid leukemia: Evidence for blood-brain barrier disruption and glial activation.

Journal: HemaSphere
Published: July 07, 2025

Nuclear Phase Separation Drives NPM1-mutant Acute Myeloid Leukemia.

Nuclear Phase Separation Drives NPM1-mutant Acute Myeloid Leukemia.

Journal: bioRxiv : the preprint server for biology
Published: June 12, 2025

Independent Origin of Hairy Cell Leukemia (HCL) From Co-Occurring Clonal Hematopoiesis (CH).

Independent Origin of Hairy Cell Leukemia (HCL) From Co-Occurring Clonal Hematopoiesis (CH).

Journal: American journal of hematology
Published: May 12, 2025

Targetable Mutations in BRAF V600E-Negative Hairy-Cell Leukemia.

Targetable Mutations in BRAF V600E-Negative Hairy-Cell Leukemia.

Journal: The New England journal of medicine
Published: April 11, 2025

Dissecting CD47 expression in lymphoid neoplasms to inform precision immunotherapy with anti-CD47 phagocytic checkpoint blockade.

Dissecting CD47 expression in lymphoid neoplasms to inform precision immunotherapy with anti-CD47 phagocytic checkpoint blockade.

Journal: Haematologica
Published: March 19, 2025

B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with MYC and BCL2 Rearrangements.

B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with MYC and BCL2 Rearrangements.

Journal: Blood cancer discovery
Published: March 19, 2025

Hairy-Cell Leukemia. Reply.

Hairy-Cell Leukemia. Reply.

Journal: The New England journal of medicine
Published: December 18, 2024
Showing 1-12 of 186

Last Updated: 09/26/2026